Literature DB >> 17728480

Pregnancy-associated plasma protein-a levels are related to glycemic control but not to lipid profile or hemostatic parameters in type 2 diabetes.

Silvia Pellitero1, Jordi L Reverter, Eduarda Pizarro, Maria Cruz Pastor, Maria Luisa Granada, Dolors Tàssies, Juan-Carlos Reverter, Isabel Salinas, Anna Sanmartí.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17728480     DOI： 10.2337/dc07-1092

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  5 in total

1.  Multi-biomarker strategy for prediction of myocardial dysfunction and mortality in sepsis.

Authors:  Fa-Chao Chen; Yin-Chuan Xu; Zhao-Cai Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2020-07       Impact factor: 3.066

2.  Pregnancy-associated plasma protein-A is a stronger predictor for adverse cardiovascular outcomes after acute coronary syndrome in type-2 diabetes mellitus.

Authors:  Wei-Ping Li; Moni B Neradilek; Fu-Sheng Gu; Daniel A Isquith; Zhi-Jun Sun; Xing Wu; Hong-Wei Li; Xue-Qiao Zhao
Journal:  Cardiovasc Diabetol       Date:  2017-04-05       Impact factor: 9.951

3.  Prediction of Gestational Diabetes by Measuring the Levels of Pregnancy Associated Plasma Protein-A (PAPP-A) During Gestation Weeks 11-14.

Authors:  Somayeh Ramezani; Mahboubeh Ahmadi Doulabi; Hamid Saqhafi; Mahmood Alipoor
Journal:  J Reprod Infertil       Date:  2020 Apr-Jun

4.  First Trimester Aneuploidy Screening Markers in Women with Pre-Gestational Diabetes Mellitus.

Authors:  Padmalatha Gurram; Peter Benn; James Grady; Anne-Marie Prabulos; Winston Campbell
Journal:  J Clin Med       Date:  2014-05-08       Impact factor: 4.241

5.  First trimester prenatal screening biomarkers and gestational diabetes mellitus: A systematic review and meta-analysis.

Authors:  Brittney M Donovan; Nichole L Nidey; Elizabeth A Jasper; Jennifer G Robinson; Wei Bao; Audrey F Saftlas; Kelli K Ryckman
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.